These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Left ventricular lead position and nonspecific conduction delay are predictors of mortality in patients during cardiac resynchronization therapy. Prochnau D; Kuehnert H; Heinke M; Figulla HR; Surber R Can J Cardiol; 2011; 27(3):363-8. PubMed ID: 21507601 [TBL] [Abstract][Full Text] [Related]
29. Left ventricular versus biventricular pacing in cardiac resynchronization therapy: the plot in this tale of two modes. Kass D J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1348-9. PubMed ID: 15610276 [No Abstract] [Full Text] [Related]
30. Color Doppler tissue velocity imaging can disclose systolic left ventricular asynchrony independent of the QRS morphology in patients with severe heart failure. Schuster P; Faerestrand S; Ohm OJ Pacing Clin Electrophysiol; 2004 Apr; 27(4):460-7. PubMed ID: 15078398 [TBL] [Abstract][Full Text] [Related]
31. QRS morphology, left ventricular lead location, and clinical outcome in patients receiving cardiac resynchronization therapy. Kandala J; Upadhyay GA; Altman RK; Parks KA; Orencole M; Mela T; Kevin Heist E; Singh JP Eur Heart J; 2013 Aug; 34(29):2252-62. PubMed ID: 23571836 [TBL] [Abstract][Full Text] [Related]
32. Effect of cardiac resynchronization therapy on cerebral blood flow. van Bommel RJ; Marsan NA; Koppen H; Delgado V; Borleffs CJ; Ypenburg C; Bertini M; Schalij MJ; Bax JJ Am J Cardiol; 2010 Jul; 106(1):73-7. PubMed ID: 20609651 [TBL] [Abstract][Full Text] [Related]
33. [Clinical case of significant "reverse remodeling" after cardiac resynchronization therapy]. Falcone A; Ranalli G; Luise R; Di Giammarco G; De Caterina R; Mobilij A Ital Heart J Suppl; 2003 Apr; 4(4):337-9. PubMed ID: 12784769 [TBL] [Abstract][Full Text] [Related]
34. Cardiac resynchronization therapy in patients with intrinsic and right ventricular pacing-induced left bundle branch block pattern. Shen X; Aronow WS; Holmberg MJ; Li H; Nair CK; Korlakunta H; Esterbrooks DJ Am J Ther; 2009; 16(6):e44-50. PubMed ID: 19940605 [TBL] [Abstract][Full Text] [Related]
35. Cardiac resynchronization therapy in patients with a narrow QRS complex. Bleeker GB; Holman ER; Steendijk P; Boersma E; van der Wall EE; Schalij MJ; Bax JJ J Am Coll Cardiol; 2006 Dec; 48(11):2243-50. PubMed ID: 17161254 [TBL] [Abstract][Full Text] [Related]
36. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Linde C; Gold M; Abraham WT; Daubert JC; Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890 [TBL] [Abstract][Full Text] [Related]
37. Usefulness of tissue Doppler velocity and strain dyssynchrony for predicting left ventricular reverse remodeling response after cardiac resynchronization therapy. Yu CM; Gorcsan J; Bleeker GB; Zhang Q; Schalij MJ; Suffoletto MS; Fung JW; Schwartzman D; Chan YS; Tanabe M; Bax JJ Am J Cardiol; 2007 Oct; 100(8):1263-70. PubMed ID: 17920368 [TBL] [Abstract][Full Text] [Related]